Drug Profile
NSD 644
Alternative Names: NSD-644Latest Information Update: 02 Feb 2009
Price :
$50
*
At a glance
- Originator NeuroSearch
- Developer GlaxoSmithKline; NeuroSearch
- Class Analgesics; Neuropsychotherapeutics
- Mechanism of Action Adrenergic receptor antagonists; Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS disorders; Neuropathic pain
Most Recent Events
- 29 Jan 2009 Discontinued - Phase-I for CNS disorders in Germany (unspecified route)
- 29 Jan 2009 Discontinued - Phase-I for Neuropathic pain in Germany (unspecified route)
- 03 Dec 2007 Phase-I clinical trials in CNS disorders in Germany (unspecified route)